The need to infuse drugs lrntant to peripheral veins (e.g. antibiotics, phenytoin, calcium), to administer parenteral nutrition, to measure central venous pressure, and to deliver chemically incompatible drugs, often means that critically ill patients need more than one central line. This had previously been achieved by cannulating several large veins, by inserting a number of catheters through the same venipuncture site using several wire-guides, or by multiple, separate punctures of the same vein.
The complications from introducing several central lines include catheter emboli, knotting and sepsis. The use of a single-lumen catheter with multiple infusion sets via Y -connectors or 3-way taps may also present problems: 
The Catheter
The 5 French gauge (Fr) 30 cm usable length, quadruple-lumen catheter became commercially available from Edwards Laboratories Division of AHS in mid-1982. It is radio-opaque, has 4 colour-coded, Luerlok ports, may be heparin-coated and has markings at 5 cm intervals.
It is ethylene oxide sterilised and has two small and two large lumina. The large ones will allow crystalloid infusion under gravity and central venous pressure measurement with a manometer; the small lumina are used for central venous pressure measurement with a transducer and for concentrated drug infusion.
The catheter was derived from two prototypes which have been in use In our institution for over three years. The quadruple-lumen catheter is placed in a central vein J ,2 percutaneously using Seldinger wire-guide technique,3 using a dilator and 5.5 Fr peel-away sheath (Cook Inc.).
DISCUSSION
Each port can be connected by means of a short length of Luerlok tubing with no injection ports to a syringe pump, central venous pressure manometer, infusion pump, transducer or infusion set. Any remaining lumina which are not required are sealed with a Luerlok bung and kept flushed with heparinised saline.
In our experience with the catheter over the past year we have found that the dedication of one line to one drug has meant that we are able to infuse concentrated drug solutions without the risk of inadvertent dosage fluctuations and to infuse chemically incompatible drugs concurrently through the same venous access site.
To facilitate the preparation of the concentrated solutions, a series of dilution charts for commonly-used inotropes and vasodilators has been constructed and is available from the authors.
In 1982, a double-lumen catheter was described for similar purposes. 4 In our three years' experience with the triple-and quadruple-lumen catheters which we designed, we have been impressed with their versatility and ease of insertion. They are now commercially available.
